Literature DB >> 24836

Multiple endocrine adenomatosis (Type I) and familial hyperparathyroidism.

R T Jung, A M Grant, M Davie, D Jenkins, T M Chalmers.   

Abstract

Hyperparathyroidism is the commonest presenting feature in multiple endocrine adenomatosis Type I (MEA Type I), the other manifestations may be delayed for many years or appear only in relatives. A family now diagnosed as MEA Type I, who was previously thought, in 1965, to have familial hyperparathyroidism due to chief cell hyperplasia is now described. The importance is stressed of family surveillance and long-term follow-up in all cases of primary hyperparathyroidism. Those tests that are essential in the long-term surveillance of the patients and their first degree relatives are discussed.

Entities:  

Mesh:

Year:  1978        PMID: 24836      PMCID: PMC2425057          DOI: 10.1136/pgmj.54.628.92

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

1.  PRIMARY CHIEF CELL HYPERPLASIA OF THE PARATHYROID GLANDS.

Authors:  P H ADAMS; T CHALMERS; N PETERS; J H RACK; B M TRUSCOTT
Journal:  Ann Intern Med       Date:  1965-09       Impact factor: 25.391

2.  Stimulation tests for diagnosis of medullary thyroid carcinoma.

Authors:  G W Sizemore; V L Go
Journal:  Mayo Clin Proc       Date:  1975-02       Impact factor: 7.616

3.  Parathyroid hyperplasia in primary hyperparathyroidism: a review of 85 cases.

Authors:  B Castleman; A Schantz; S Roth
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

4.  Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid.

Authors:  G W Sizemore; V L Go; E L Kaplan; L J Sanzenbacher; K H Holtermuller; C D Arnaud
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

5.  Immunoassay of human calcitonin.

Authors:  A H Tashijan; B G Howland; K E Melvin; C S Hill
Journal:  N Engl J Med       Date:  1970-10-22       Impact factor: 91.245

6.  Occurrence of other endocrine tumours in primary hyperparathyroidism.

Authors:  J H Boey; T J Cooke; G M Gilbert; E C Sweeney; S Taylor
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

7.  Familial hyperparathyroidism.

Authors:  N Peters; T M Chalmers; B M Truscott; J H Rack; P H Adams
Journal:  Postgrad Med J       Date:  1966-04       Impact factor: 2.401

8.  Multiple endocrine adenomatosis of mixed type.

Authors:  O P Hansen; M Hansen; H H Hansen; B Rose
Journal:  Acta Med Scand       Date:  1976
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.